Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

69 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

FRANCE

NOUVELLE AQUITAINE
LIMOGES

Ongoing trial
AmyDara: A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better - FR
CHU de Limoges - Hôpital Dupuytren
Service d'hématologie clinique et de thérapie cellulaire

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
An open-label, phase 1/2 study of melflufen and dexamethasone for patients with al amyloidosis following at least one prior line of therapy - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

PORTUGAL

NORTE
PORTO

Recruiting trial
Ongoing trial
Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis (Phase I)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTUGAL

NORTE
PORTO

Ongoing trial
Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis (Phase II/III)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTUGAL

SUL
LISBOA

Ongoing trial
Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis (Phase II/III)
Hospital de Sta. Maria - Centro Hospitalar de Lisboa Norte, EPE.
Serviço de Neurologia

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for untreated patients with systemic light-chain (AL) amyloidosis - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

Multinational clinical trial(s)

FRANCE

ILE-DE-FRANCE
PARIS

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US